ANPEP and lung carcinoma: In subgroup analyses lung cancer patients in tumor stage I (n = 577 patients) had an increased overall survival in case CD13 mRNA expression was observed (p = 0.0035; HR = 0.67 (95%-CI: 0.51–0.88)).